Suchergebnisse - "Tovazzi, Valeria"

PubPharm (24)

1

SARS-CoV-2 omicron (B.1.1.529)-related COVID-19 sequelae in vaccinated and unvaccinated patients with cancer : results from the OnCovid registry

enthalten in: The Lancet. Oncology | 2023

von Cortellini, A. | Tabernero, J. | Mukherjee, U. | +126

2

Outcomes of the SARS-CoV-2 omicron (B.1.1.529) variant outbreak among vaccinated and unvaccinated patients with cancer in Europe : results from the retrospective, multicentre, OnCovid registry study

enthalten in: The Lancet. Oncology | 2022

von Pinato, D. | Aguilar-Company, J. | Ferrante, D. | +147

3

Prevalence and impact of COVID-19 sequelae on treatment and survival of patients with cancer who recovered from SARS-CoV-2 infection : evidence from the OnCovid retrospective, multicentre registry study

enthalten in: The Lancet. Oncology | 2021

von Pinato, D. | Tabernero, J. | Bower, M. | +130

4

Outcome of patients with intrathyroidal thymic carcinoma : a pooled analysis

enthalten in: Endocrine-related cancer | 2021

von Gurizzan, C. | Zamparini, M. | Volante, M. | +7

5

Determinants of enhanced vulnerability to coronavirus disease 2019 in UK patients with cancer : a European study

enthalten in: European journal of cancer (Oxford, England : 1990) | 2021

von Pinato, D. | Scotti, L. | Gennari, A. | +67

CommentIn: Lancet Oncol. 2021 Jun;22(6):755. - PMID 33894836

6

Systemic pro-inflammatory response identifies patients with cancer with adverse outcomes from SARS-CoV-2 infection : the OnCovid Inflammatory Score

enthalten in: Journal for immunotherapy of cancer | 2021

von Dettorre, G. | Dolly, S. | Loizidou, A. | +59

ErratumIn: J Immunother Cancer. 2021 Jun;9(6):. - PMID 34135105

7

Accurate Triage of Oncological Patients for Safely Continuing Cancer Therapy During the SARS-CoV-2 Pandemic

enthalten in: Frontiers in oncology | 2021

von Gurizzan, C. | Pedersini, R. | Fornaro, C. | +17

8

Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome

enthalten in: Endocrine | 2021

von Tovazzi, V. | Ferrari, V. | Berruti, A.

CommentOn: Endocrine. 2020 Sep;69(3):481-484. - PMID 32488839

9

Maintenance everolimus beyond progression in pancreatic NET to control insulinoma syndrome

enthalten in: Endocrine | 2021

von Tovazzi, V. | Ferrari, V. | Berruti, A.

10

Should everolimus be stopped after radiological progression in metastatic insulinoma? A "cons" point of view

enthalten in: Endocrine | 2020

von Tovazzi, V. | Ferrari, V. | Dalla Volta, A. | +3

CommentIn: Endocrine. 2021 Jan;71(1):256-257. - PMID 33394384